Delivery Order SPE2DP18D0006-SPE2DP19F0524
Award Date 11/1/18
Potential Completion Date 11/12/18
Potential Value $3.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to GlaxoSmithKline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. The order was issued under contract SPE2DP18D0006 and has a firm fixed price ceiling value of $17,193.60. The order was awarded on October 16, 2018, with a performance completion date of November 5, 2018. The contract does not have a set-aside designation. GlaxoSmithKline has received multiple federal contract awards and grants...
- This federal contract award, with ID SPE2DP18D0006|SPE2DP19F0455, was issued by the Defense Logistics Agency (DLA) to the prime contractor Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The contract is for the delivery of influenza virus vaccine, with a ceiling value of $56,050. The contract type is Delivery Order with Firm Fixed Price pricing. The contract has no set-aside designation...
- This federal contract award, with ID SPE2DP18D0006|SPE2DP19F0456, was issued by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. The contract is a firm fixed-price Delivery Order with a ceiling value of $173,368.80 and a period of performance ending on November 8, 2018. The contract was not set aside for any specific business designation. Glaxosmithkline, LLC has provided a range of pharmaceutical goods and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC, a pharmaceutical company, for the supply of 8502637428 influenza virus vaccine. The $100,660.00 contract has a performance period ending on November 30, 2015 and was not set aside for any socioeconomic category. Glaxosmithkline holds multiple federal contract vehicles with agencies like the Department of Veterans Affairs, Centers for Disease Control and Prevention, and DLA to...
- This is a firm fixed price delivery order contract awarded by the Medical Supply Chain division of the Defense Department's Defense Logistics Agency (DLA) to GlaxoSmithKline, LLC for the provision of influenza virus vaccines. The contract has a ceiling value of $2,405,037.60 and a period of performance ending on September 30, 2016. The contract was not set aside for any specific business category. GlaxoSmithKline, a pharmaceutical company that provides vaccines and other products to U.S....
- This federal contract award, SPE2DP18D0006|SPE2DP19F0375, was issued by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC for the delivery of influenza virus vaccines. The $53,730.00 firm fixed price delivery order has a period of performance ending on November 7, 2018 and was placed under a larger DLA pharmaceutical supply contract vehicle. The contract does not have a set-aside designation. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, has also received other...
- This federal contract award, valued at $9,033,542.56, was issued by the Defense Department's Medical Supply Chain agency to Glaxosmithkline, LLC, a pharmaceutical company, for the delivery of influenza virus vaccines. The contract has a firm fixed price structure and an ultimate completion date of October 17, 2016. It is not designated as a set-aside contract. Glaxosmithkline has provided a range of pharmaceutical goods and services to various federal agencies, including vaccines, antiviral...
- This is a delivery order contract (SPE2DP19F0724) awarded by the U.S. Department of Defense (DoD) Medical Supply Chain to Glaxosmithkline, LLC for the provision of influenza virus vaccine. The $3,582 firm fixed price contract has a completion date of November 30, 2018 and does not utilize a set-aside designation. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, has provided a range of vaccines and antiviral medications to federal agencies through multiple indefinite delivery...
- The U.S. government's Bureau of Administration, a civilian agency, awarded a firm fixed-price delivery order contract to GlaxoSmithKline, LLC for the provision of 2025-2026 influenza vaccines. The contract has a ceiling value of $667,575.00 and an ultimate completion date of October 9, 2025. This award is not set aside for any specific business type. GlaxoSmithKline, a foreign-owned, for-profit pharmaceutical company, has been a critical supplier of vaccines, antivirals, and medical...
- This federal contract award with ID SPE2DP24D0005|SPE2DP24F3249 is for the delivery of influenza virus vaccines. The contract was awarded on March 14, 2024 to the prime contractor Glaxosmithkline, LLC, doing business as Glaxosmithkline, a pharmaceutical company that provides vaccines, antivirals, and other pharmaceutical products to U.S. government agencies. The contract has a ceiling value of $1,551,550.00 and is a firm fixed price delivery order contract with no set-aside designation. The...